HomeInvestors HealthAstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy... AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition (AZN:NASDAQ) By BOMAR ENT. March 17, 2025 FacebookTwitterPinterestWhatsApp Roland Magnusson EsoBiotec SA has entered into a definitive agreement to be acquired by AstraZeneca (NASDAQ:AZN) for up to $1 billion, on a cash and debt-free basis, it said on Monday. The deal includes an initial payment of $425 million on closing, and up Source link Previous articleBeating the StreetNext articleKnit Socks!: 17 Classic Patterns for Cozy Feet latest articles explore more Stock Market Basics For Beginners: Smart Stock Market Trading with Low Capital (Stock Market Basics to Advance) PepsiCo to Acquire Healthy Soda Brand Poppi For $1.65 Billion Trouble Brewing, But Don't Short Now Options Trading for Beginners: One-Stop Guide to Master the Basics, Manage Risk, and Maximize Profit, Even If You Have No Experience Knit Socks!: 17 Classic Patterns for Cozy Feet Beating the Street LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
